[go: up one dir, main page]

DK1076650T3 - Arylfusionerede, azapolycykliske forbindelser - Google Patents

Arylfusionerede, azapolycykliske forbindelser

Info

Publication number
DK1076650T3
DK1076650T3 DK99910600T DK99910600T DK1076650T3 DK 1076650 T3 DK1076650 T3 DK 1076650T3 DK 99910600 T DK99910600 T DK 99910600T DK 99910600 T DK99910600 T DK 99910600T DK 1076650 T3 DK1076650 T3 DK 1076650T3
Authority
DK
Denmark
Prior art keywords
aryl fused
fused azapolycyclic
azapolycyclic compounds
compounds
aryl
Prior art date
Application number
DK99910600T
Other languages
English (en)
Inventor
Jotham Wadsworth Coe
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DK1076650T3 publication Critical patent/DK1076650T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Anesthesiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
DK99910600T 1998-04-29 1999-04-08 Arylfusionerede, azapolycykliske forbindelser DK1076650T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8355698P 1998-04-29 1998-04-29
PCT/IB1999/000617 WO1999055680A1 (en) 1998-04-29 1999-04-08 Aryl fused azapolycyclic compounds

Publications (1)

Publication Number Publication Date
DK1076650T3 true DK1076650T3 (da) 2004-05-24

Family

ID=22179102

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99910600T DK1076650T3 (da) 1998-04-29 1999-04-08 Arylfusionerede, azapolycykliske forbindelser

Country Status (42)

Country Link
US (3) US6462035B1 (da)
EP (1) EP1076650B1 (da)
JP (1) JP2002513007A (da)
KR (1) KR100420423B1 (da)
CN (1) CN1144787C (da)
AP (1) AP1154A (da)
AR (1) AR018596A1 (da)
AT (1) ATE258921T1 (da)
AU (1) AU749831B2 (da)
BG (1) BG64556B1 (da)
BR (1) BR9910058A (da)
CA (1) CA2330576A1 (da)
CO (1) CO5021124A1 (da)
DE (1) DE69914594T2 (da)
DK (1) DK1076650T3 (da)
DZ (1) DZ2778A1 (da)
EA (1) EA003669B1 (da)
ES (1) ES2213354T3 (da)
GT (1) GT199900059A (da)
HK (1) HK1036453A1 (da)
HR (1) HRP20000731A2 (da)
HU (1) HUP0103340A3 (da)
ID (1) ID26700A (da)
IL (1) IL138917A0 (da)
IS (1) IS5649A (da)
MA (1) MA26623A1 (da)
MY (1) MY133474A (da)
NO (1) NO317300B1 (da)
NZ (1) NZ507035A (da)
OA (1) OA11506A (da)
PA (1) PA8471301A1 (da)
PE (1) PE20000435A1 (da)
PL (1) PL344010A1 (da)
PT (1) PT1076650E (da)
SK (1) SK15952000A3 (da)
TN (1) TNSN99080A1 (da)
TR (1) TR200003122T2 (da)
UA (1) UA61991C2 (da)
UY (1) UY25636A1 (da)
WO (1) WO1999055680A1 (da)
YU (1) YU64400A (da)
ZA (1) ZA992971B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999035131A1 (en) * 1997-12-31 1999-07-15 Pfizer Products Inc. Aryl fused azapolycyclic compounds
US6605610B1 (en) 1997-12-31 2003-08-12 Pfizer Inc Aryl fused azapolycyclic compounds
US20010036943A1 (en) * 2000-04-07 2001-11-01 Coe Jotham W. Pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines
AU2002234836B2 (en) 2001-04-20 2007-08-23 Pfizer Products Inc. Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
CA2460118A1 (en) * 2001-10-31 2003-05-08 Pfizer Products Inc. Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome
RU2004116320A (ru) 2001-11-30 2005-10-10 Пфайзер Продактс Инк. (Us) Арилконденсированные азаполициклические соединения
US20060089400A1 (en) * 2002-05-03 2006-04-27 The Vernalis Group Of Companies Novel spiro ketone and carboxylic acid derivatives as specific inhibitors for (po3h2) ser/(po3h2)thr-pro-specific peptidyl-prolylcis/trans-isomerases
US20040224963A1 (en) * 2003-05-09 2004-11-11 Pfizer Inc Pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal
US20040224962A1 (en) * 2003-05-09 2004-11-11 Pfizer Inc Pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss
ATE443705T1 (de) 2003-07-21 2009-10-15 Pfizer Prod Inc Nikotin abhängigkeit reduzierende heteroaryl kondensierte azapolycyclische verbindungen
CA2533100A1 (en) * 2003-07-21 2005-01-27 Pfizer Products Inc. Aryl fused azapolycyclic compounds
US20050043407A1 (en) * 2003-08-22 2005-02-24 Pfizer Inc Pharmaceutical composition for the prevention and treatment of addiction in a mammal
ATE395348T1 (de) * 2004-12-07 2008-05-15 Pfizer Prod Inc 1,2,3,3a;8,8a-hexahydro-2,7a- diazacyclopenta(a)inden-7-onderivate, die sich an neuronale nikotinische acetylcholinspezifische rezeptorstellen binden und zur modulation der cholinergen funktion und zur behandlung von suchterkrankungen eignen
US20060210497A1 (en) * 2005-03-18 2006-09-21 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Novel resorcinol derivatives
US20060210498A1 (en) * 2005-03-18 2006-09-21 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Novel resorcinol derivatives for skin
DE102005061426A1 (de) * 2005-12-22 2007-07-05 Grünenthal GmbH Substituierte tricyclische Piperidon-Derivate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3687937A (en) * 1970-06-23 1972-08-29 Us Of America The 1,5-methano-3-benzazocine derivatives
JPS4914473A (da) * 1972-06-09 1974-02-07
JPS4924968A (da) * 1972-07-01 1974-03-05

Also Published As

Publication number Publication date
TNSN99080A1 (fr) 2005-11-10
HRP20000731A2 (en) 2001-06-30
JP2002513007A (ja) 2002-05-08
PA8471301A1 (es) 2000-09-29
EP1076650A1 (en) 2001-02-21
PT1076650E (pt) 2004-05-31
US20040167149A1 (en) 2004-08-26
AR018596A1 (es) 2001-11-28
US7122534B2 (en) 2006-10-17
HUP0103340A3 (en) 2002-10-28
CN1144787C (zh) 2004-04-07
PL344010A1 (en) 2001-09-24
NZ507035A (en) 2003-05-30
UA61991C2 (en) 2003-12-15
DZ2778A1 (fr) 2005-04-23
TR200003122T2 (tr) 2001-03-21
KR20010043143A (ko) 2001-05-25
CA2330576A1 (en) 1999-11-04
HUP0103340A2 (hu) 2002-02-28
KR100420423B1 (ko) 2004-03-04
GT199900059A (es) 2000-10-11
AU2951699A (en) 1999-11-16
AP1154A (en) 2003-03-27
ES2213354T3 (es) 2004-08-16
IS5649A (is) 2000-09-29
DE69914594D1 (de) 2004-03-11
SK15952000A3 (sk) 2002-06-04
PE20000435A1 (es) 2000-05-26
UY25636A1 (es) 2000-02-23
CO5021124A1 (es) 2001-03-27
NO20005397L (no) 2000-10-26
ZA992971B (en) 2000-10-30
US6462035B1 (en) 2002-10-08
EA003669B1 (ru) 2003-08-28
HK1036453A1 (en) 2002-01-04
WO1999055680A1 (en) 1999-11-04
BG104983A (en) 2001-09-28
US20030008890A1 (en) 2003-01-09
NO20005397D0 (no) 2000-10-26
CN1298394A (zh) 2001-06-06
AU749831B2 (en) 2002-07-04
DE69914594T2 (de) 2004-12-09
ID26700A (id) 2001-02-01
US6706702B2 (en) 2004-03-16
OA11506A (en) 2004-05-14
EP1076650B1 (en) 2004-02-04
ATE258921T1 (de) 2004-02-15
EA200000996A1 (ru) 2001-06-25
MA26623A1 (fr) 2004-12-20
BG64556B1 (bg) 2005-07-29
NO317300B1 (no) 2004-10-04
AP9901524A0 (en) 1999-06-30
YU64400A (sh) 2003-01-31
IL138917A0 (en) 2001-11-25
BR9910058A (pt) 2000-12-26
MY133474A (en) 2007-11-30

Similar Documents

Publication Publication Date Title
DK1259489T3 (da) Arylfusionerede, azapolycykliske forbindelser
CY2008013I1 (el) Αρυλσυμπυκωμενες αζαπολυκυκλικες ενωσεις
LTPA2009006I1 (lt) Trombopoetino junginiai
ATE229954T1 (de) Betacarbolinverbindungen
ID28266A (id) Senyawa-senyawa amidin
FI980427A0 (fi) Foerfarande, arrangemang och anordning foer verifiering
NO20011745L (no) Forbindelser
FI4209U1 (fi) Uusia yhdisteitä
ID27004A (id) Senyawa-senyawa kalsilitik
DK1076650T3 (da) Arylfusionerede, azapolycykliske forbindelser
NO20006662L (no) Fluorfenylresin-forbindelser
FI980633A0 (fi) Uppsamlingsanordning foer engaongsbruk foer uppsamling av loest material, saosom hundavfoering, fraon ett underlag
FI980638A0 (fi) Foerfarande, arrangemang och anordning foer telekommunikation
SE9800509D0 (sv) New Compounds
SE9800834D0 (sv) New Compounds
SE9800977D0 (sv) New compounds
SE9801099D0 (sv) New compounds
SE9803746D0 (sv) New compounds
SE9800512D0 (sv) New compounds
SE9800510D0 (sv) New Compounds
SE9800508D0 (sv) New Compounds
SE9800511D0 (sv) New compounds
SE9803747D0 (sv) New compounds
SE9800626D0 (sv) Compounds
IDP000021790A (id) Senyawa-senyawa pirolum tersubstitusi